COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 683: Articles 6821-6830  | Next

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
Schrom, J., Marquez, C., Wang, C.-Y., Saxena, A., Mitchell, A., Ribeiro, S., Pilarowski, G., Nakamura, R., Rojas, S., Black, D., Contreras Oseguera, M., Castellanos Diaz, E., Payan, J., Rojas, S., Jones, D., Tulier-Laiwa, V., Zavaleta, A., Martinez, J., Chamie, G., Glaser, C., Jacobson, K., Petersen, M., DeRisi, J., Havlir, D.
10.1101/2022.08.17.22278913 — Posted: 2022-08-18
Prevalence and Characterization of Bacteria Present in the Nasopharynx of Outpatients with and without SARS-CoV-2
Shurko, J., Mares, C. A., Page, R. B., Lopez, K., Nguyen, V., Vanee, N., Mishra, P. K.
10.1101/2022.08.17.22278915 — Posted: 2022-08-18
Genetic diversity and spread dynamics of SARS-CoV-2 variants present in African populations
Mtetwa, D., Mutetwa, T. F., Manjengwa, T., Mazadza, A., Chikwambi, Z.
10.1101/2022.08.17.504290 — Posted: 2022-08-17
Natural variations within the glycan shield of SARS-CoV-2 impact viral spike dynamics
Newby, M. L., Fogarty, C. A., Allen, J. D., Butler, J., Fadda, E., Crispin, M.
10.1101/2022.08.17.504157 — Posted: 2022-08-17
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Wamhoff, E.-C., Ronsard, L., Feldman, J., Hauser, B. M., Knappe, G. A., Romanov, A., Lam, E., St. Denis, K., Balazs, A. B., Schmidt, A., Lingwood, D., Bathe, M.
10.1101/2022.08.16.504128 — Posted: 2022-08-17
Antigen Specific T Cells in People with Obesity at Five Months Following ChAdOx1 COVID-19 Vaccination
Wrigley-Kelly, N. E., DeBarra, C., Shaamile, F., Holland, A., Shaw, L., Mallon, P. W. G., O'Connell, J., Hogan, A. E., O'Shea, D.
10.1101/2022.08.16.22278821 — Posted: 2022-08-17
Impact of the COVID-19 pandemic on the socioeconomic inequality of health behavior among Japanese adolescents: a two-year-repeated cross-sectional survey
Kyan, A., Takakura, M.
10.1101/2022.08.11.22278499 — Posted: 2022-08-17
Long-term changes in human mobility responses to COVID-19-related information in Japan
Fukui, S.
10.1101/2022.08.15.22278703 — Posted: 2022-08-17
The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys
Giorgi Rossi, P., Carrozzi, G., Falini, P., Sampaolo, L., Gorini, G., Zorzi, M., Armaroli, P., Senore, C., Sassoli de Bianchi, P., Masocco, M., Zappa, M., Battisti, F., Mantellini, P.
10.1101/2022.08.15.22278787 — Posted: 2022-08-17
Revealing geographic transmission pattern of COVID-19 using neighborhood-level simulation with human mobility data and SEIR model: A Case Study of South Carolina
Ning, H., Li, Z., Qiao, S., Zeng, C., Zhang, J., Olatosi, B., Li, X.
10.1101/2022.08.16.22278809 — Posted: 2022-08-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).